Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Novarel Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
During the historical timeframe, growth was primarily propelled by the proliferation of fertility treatment clinics, the established clinical application of hCG therapies, rising infertility diagnosis rates, the availability of injectable hormone formulations, and the expansion of reproductive endocrinology practices.
Anticipated growth over the forecast period stems from the escalating adoption of advanced fertility treatments, the upward trend in maternal age, the broader implementation of personalized fertility protocols, increasing investments in reproductive health services, and a heightened demand for outpatient fertility therapies. Key developments anticipated during this period encompass a heightened need for fertility hormone therapies, the expanding application of injectable gonadotropins, the wider availability of assisted reproductive treatments, an elevated emphasis on hormone monitoring protocols, and greater tailored clinical approaches to fertility care.
Get A Free Sample Report With In-Depth Market Insights:
Novarel Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing occurrence of infertility is projected to boost the expansion of the novarel market in the future. Infertility is defined as the inability to achieve pregnancy after a year of consistent, unprotected sexual activity or the incapacity to carry a pregnancy to term. The growing worldwide infertility rates are escalating the need for fertility interventions, especially ovulation induction involving hCG therapies like Novarel, as women search for remedies to address ovulation challenges. Novarel aids in addressing infertility by stimulating ovulation in women facing difficulty releasing eggs and by supporting sperm production in men with low testosterone, consequently enhancing the prospects of conception. For example, in April 2023, the World Health Organization (WHO) reported that approximately 17.5% of the global adult population, equating to about 1 in 6 individuals, suffers from infertility. This rising prevalence of infertility is, therefore, a key driver for the novarel market. An increase in healthcare spending is anticipated to propel the expansion of the novarel market moving forward. This rise in healthcare expenditure is influenced by factors such as the growing occurrence of chronic illnesses, an aging demographic, and continuous progress in medical technologies. Healthcare spending benefits novarel by ensuring availability of effective infertility solutions, including human chorionic gonadotropin (hCG), which is crucial for stimulating ovulation and enhancing fertility results, thereby promoting more precise and effective care in reproductive health. For instance, in May 2024, a report from the Office For National Statistics, a UK-based government agency, indicated that overall healthcare spending increased by 5.6% in nominal terms between 2022 and 2023, representing a significant acceleration compared to the 0.9% rise documented in 2022. Consequently, the uptick in healthcare spending is fueling the novarel market.
Novarel Market Breakdown By Product Type And Application
The novarel market covered in this report is segmented –
1) By Indication: Induction Of Ovulation, Hypogonadotropic Hypogonadism, Fertility Preservation
2) By Distribution Channel: Hospital, Pharmacies, Online Pharmacies
3) By End User: Adult, Geriatric
Novarel Market Company Landscape And Competitive Strategy
Major companies operating in the novarel market are Ferring Pharmaceuticals Inc.
View The Full Novarel Market Report:
Novarel Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the novarel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novarel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model